Legal & General Group
ENFN

Legal & General Group’s Enfusion, Inc. ENFN Stock Holding History

Legal & General Group’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-42,226
Closed -$471K – 3583
2025
Q1 		$471K Sell
42,226
-3,063
-7% -$33.9K ﹤0.01% 2411
2024
Q4 		$466K Buy
45,289
+3,938
+10% +$38.1K ﹤0.01% 2482
2024
Q3 		$392K Buy
41,351
+4,168
+11% +$36K ﹤0.01% 2540
2024
Q2 		$317K Buy
37,183
+6,493
+21% +$59.4K ﹤0.01% 2582
2024
Q1 		$284K Buy
30,690
+4,515
+17% +$39.7K ﹤0.01% 2619
2023
Q4 		$254K Buy
26,175
+10,547
+67% +$98.5K ﹤0.01% 2664
2023
Q3 		$140K Sell
15,628
-1,356
-8% -$12.9K ﹤0.01% 2787
2023
Q2 		$191K Buy
16,984
+5,200
+44% +$46.1K ﹤0.01% 2746
2023
Q1 		$124K Buy
11,784
+1,940
+20% +$21.4K ﹤0.01% 2732
2022
Q4 		$95.2K Buy
9,844
+674
+7% +$7.59K ﹤0.01% 2831
2022
Q3 		$113K Sell
9,170
-6,776
-42% -$82.7K ﹤0.01% 2783
2022
Q2 		$163K Buy
15,946
+13,765
+631% +$152K ﹤0.01% 2709
2022
Q1 		$28K Buy
2,181
+67
+3% +$1.02K ﹤0.01% 3148
2021
Q4 		$44K Buy
+2,114
New +$42.7K ﹤0.01% 3062

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Legal & General Group's ENFN Position: Q2 2025 in Review

Legal & General Group sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 42,226 shares — an estimated $471K sold.

Legal & General Group first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $471K in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Legal & General Group reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 42,226 Enfusion, Inc. shares in Q2 2025, an estimated $471K.
  • Legal & General Group first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • Legal & General Group's Enfusion, Inc. position peaked at $471K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.